APTX - Aptinyx Inc
Previous close
0.061
0 0%
Share volume: 7,805,028
Last Updated: Thu 18 May 2023 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.06
0.00
0.00%
Summary score
41%
Profitability
50%
Dept financing
3%
Liquidity
50%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-11.16%
Return on assets
-10.53%
Return on sales
0%
Return on invested capital
326.36%
Total debt ratio
7.63%
Debt ratio change over timeo
-0.99%
Current Ratio
23.05%
Quick Ratio
0%
Cash Position Ratio
22.26%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.34%
Return on assets
-11.1%
Return on sales
0%
Return on invested capital
281.11%
Total debt ratio
11.67%
Debt ratio change over timeo
-0.99%
Current Ratio
24.02%
Quick Ratio
0%
Cash Position Ratio
23.01%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-10.67%
Return on assets
-10.41%
Return on sales
0%
Return on invested capital
457.83%
Total debt ratio
3.38%
Debt ratio change over time
-0.99%
Current Ratio
30.7%
Quick Ratio
0%
Cash Position Ratio
29.64%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-98.72%
Return on assets
-98.56%
Return on sales
0%
Return on invested capital
-170.65%
Total debt ratio
-98.92%
Debt ratio change over time
-0.99%
Current Ratio
-3.99%
Quick Ratio
0%
Cash Position Ratio
-5.02%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | APTX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -11.16% | 0% | 0% | 29.06% |
| Return on assets | -10.53% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | 326.36% | 0% | 0% | 47.78% |
| Profitability | 50% | 0% | 25% | 29% |
| Total debt ratio | 7.63% | 0% | 0% | 183.15% |
| Debt ratio change over time | -0.99% | 0% | 0% | 19.02% |
| Dept financing | 1% | 0% | 0% | 50% |
| Current Ratio | 24.02% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 23.01% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 34% |
| Short-term ratios | APTX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -12.34% | 0% | 0% | -16.12% |
| Return on assets | -11.1% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 281.11% | 0% | 0% | 96.56% |
| Profitability | 50% | 0% | 50% | 9% |
| Total debt ratio | 11.67% | 0% | 0% | 79.61% |
| Debt ratio change over time | -0.99% | 0% | 0% | 0.09% |
| Dept financing | 4% | 0% | 0% | 50% |
| Current Ratio | 24.02% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 23.01% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 37% |